Evidence map›Paper›PMID 39669166›Full record

ArticleHeliyon2024

A systematic review of microneedles technology in drug delivery through a bibliometric and patent overview.

Aniello Cammarano, Stefania Dello Iacono, Mario Battisti, Luca De Stefano, Caterina Meglio, Luigi Nicolais

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Enhancing vaccine stability in transdermal microneedle platforms.Drug delivery and translational research · 2025
    Review
  10. Article
  11. Review
  12. Theranostics · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aniello CammaranoMaterias Srl, Corso N. Protopisani 50, 80146, Naples, Italy.
Stefania Dello IaconoInstitute of Polymers, Composites and Biomaterials (IPCB), National Research Council, P.le Enrico Fermi 1, 80055, Portici, Italy.
Mario BattistiMaterias Srl, Corso N. Protopisani 50, 80146, Naples, Italy.
Luca De StefanoInstitute of Applied Sciences and Intelligent Systems (ISASI), National Research Council, Via P. Castellino 111, Naples, 80131, Italy.
Caterina MeglioMaterias Srl, Corso N. Protopisani 50, 80146, Naples, Italy.
Luigi NicolaisMaterias Srl, Corso N. Protopisani 50, 80146, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transdermal drug delivery (TDD) route has gathered considerable attention for its potential to improve therapeutic efficacy while minimizing systemic side effects. Among transdermal technologies, microneedle (MN) devices have proven to be a promising approach that combines the advantages of traditional needle injections and non-invasive topical applications. This review provides a comprehensive analysis of progress in transdermal drug delivery systems (TDDS) via MN from 2000 to 2023, integrating bibliometric analysis and patent landscape to present a multi-faceted perspective on the evolution of this technology. The study identifies key trends, challenges, and opportunities in the research, implementation, and commercialization of MN tools through a systematic examination of scientific literature and an extensive investigation of global patent databases. The study of bibliometric trends reveals the leading experts, organizations, companies, and countries contributing to this field, collaboration networks, and the thematic evolution of research topics. The patent analysis offers insights into innovative trajectories, key players, and geographical distribution of intellectual property. This review resumes the latest advancements in MN devices and provides a strategic outlook that can guide future research directions, promote partnerships, and inform stakeholders involved in the development of TDDS.

Indexed as

Delivery/sensingMaterialsMicroneedlePatentTransdermal drug delivery

Identifiers

PMID39669166
PMCPMC11635707

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.